| 1 | Nature Reviews Drug Discovery | 159.2 | 99th | Q1 | SCIE | – | No |
| 2 | Medicinal Research Reviews | 29.1 | 99th | Q1 | SCIE | – | No |
| 3 | Protein and Cell | 22.6 | 98th | Q1 | SCIE | – | Yes |
| 4 | Natural Product Reports | 21.2 | 97th | Q1 | SCIE | – | No |
| 5 | Molecular Therapy | 17.9 | 97th | Q1 | SCIE | – | No |
| 6 | Drug Discovery Today | 16.8 | 96th | Q1 | SCIE | – | No |
| 7 | Emerging Microbes and Infections | 14.1 | 95th | Q1 | SCIE | – | Yes |
| 8 | Archives of Pharmacal Research | 13.6 | 95th | Q1 | SCIE | – | No |
| 9 | Cell Chemical Biology | 13.6 | 94th | Q1 | SCIE | – | No |
| 10 | Phytomedicine | 13.2 | 94th | Q1 | SCIE | – | No |
| 11 | MedComm | 12.5 | 93rd | Q1 | ESCI | – | Yes |
| 12 | Pharmaceutical Biology | 12.4 | 92nd | Q1 | SCIE | – | Yes |
| 13 | Current Opinion in Pharmacology | 12.2 | 92nd | Q1 | SCIE | – | No |
| 14 | Journal of Pharmaceutical Analysis | 12 | 91st | Q1 | SCIE | – | Yes |
| 15 | Journal of Enzyme Inhibition and Medicinal Chemistry | 11.9 | 90th | Q1 | SCIE | – | Yes |
| 16 | NEJM Evidence | 11.7 | 90th | Q1 | ESCI | – | No |
| 17 | Marine Drugs | 11.6 | 89th | Q1 | SCIE | – | Yes |
| 18 | Medicine in Drug Discovery | 11.5 | 89th | Q1 | – | – | Yes |
| 19 | Nucleic Acid Therapeutics | 11.4 | 88th | Q1 | SCIE | – | No |
| 20 | EPMA Journal | 11.4 | 87th | Q1 | SCIE | – | No |
| 21 | Journal of Ethnopharmacology | 11.2 | 87th | Q1 | SCIE | – | No |
| 22 | Journal of Medicinal Chemistry | 11.1 | 86th | Q1 | SCIE | – | No |
| 23 | Molecular Therapy Nucleic Acids | 10.8 | 86th | Q1 | SCIE | – | Yes |
| 24 | European Journal of Medicinal Chemistry | 10.8 | 85th | Q1 | SCIE | – | No |
| 25 | International Journal of Nanomedicine | 10.6 | 84th | Q1 | SCIE | – | Yes |
| 26 | Molecules | 10.3 | 84th | Q1 | SCIE | – | Yes |
| 27 | Expert Opinion on Drug Discovery | 9.9 | 83rd | Q1 | SCIE | – | No |
| 28 | Expert Review of Vaccines | 9.9 | 82nd | Q1 | SCIE | – | Yes |
| 29 | Pharmaceuticals | 9 | 82nd | Q1 | SCIE | – | Yes |
| 30 | Biotechnology and Applied Biochemistry | 8.9 | 81st | Q1 | SCIE | – | No |
| 31 | Expert Opinion on Therapeutic Targets | 8.6 | 81st | Q1 | SCIE | – | No |
| 32 | Journal of Molecular Medicine | 8.6 | 80th | Q1 | SCIE | – | No |
| 33 | EXCLI Journal | 8.6 | 79th | Q1 | SCIE | – | Yes |
| 34 | Expert Opinion on Therapeutic Patents | 8.3 | 79th | Q1 | SCIE | – | No |
| 35 | Molecular Diversity | 7.9 | 78th | Q1 | SCIE | – | No |
| 36 | Current Molecular Pharmacology | 7.8 | 77th | Q1 | SCIE | – | No |
| 37 | PPAR Research | 7.8 | 77th | Q1 | SCIE | – | Yes |
| 38 | Chinese Journal of Natural Medicines | 7.7 | 76th | Q1 | SCIE | – | No |
| 39 | Vaccines | 7.7 | 76th | Q1 | SCIE | – | Yes |
| 40 | Molecular Pharmaceutics | 7.6 | 75th | Q1 | SCIE | – | No |
| 41 | ACS Bio and Med Chem Au | 7.5 | 74th | Q2 | ESCI | – | Yes |
| 42 | Mini-Reviews in Medicinal Chemistry | 7.5 | 74th | Q2 | SCIE | – | No |
| 43 | Journal of Applied Research on Medicinal and Aromatic Plants | 7.4 | 73rd | Q2 | SCIE | – | No |
| 44 | Open Medicinal Chemistry Journal | 7.3 | 72nd | Q2 | – | – | No |
| 45 | Drug Development Research | 7 | 72nd | Q2 | SCIE | – | No |
| 46 | Bioorganic Chemistry | 6.9 | 71st | Q2 | SCIE | – | No |
| 47 | Drug Design, Development and Therapy | 6.9 | 71st | Q2 | SCIE | – | Yes |
| 48 | Molecular Informatics | 6.8 | 70th | Q2 | SCIE | – | No |
| 49 | Current Gene Therapy | 6.7 | 69th | Q2 | SCIE | – | No |
| 50 | Current Topics in Medicinal Chemistry | 6.6 | 69th | Q2 | SCIE | – | No |
| 51 | Expert Opinion on Biological Therapy | 6.5 | 68th | Q2 | SCIE | – | No |
| 52 | Journal of Pharmaceutical and Biomedical Analysis | 6.5 | 68th | Q2 | SCIE | – | No |
| 53 | Archiv der Pharmazie | 6.5 | 67th | Q2 | SCIE | – | No |
| 54 | Current Medicinal Chemistry | 6.5 | 66th | Q2 | SCIE | – | No |
| 55 | Biomolecules and Therapeutics | 6.4 | 66th | Q2 | SCIE | – | No |
| 56 | Human Genomics | 6.4 | 65th | Q2 | SCIE | – | Yes |
| 57 | Journal of Natural Products | 6.3 | 64th | Q2 | SCIE | – | No |
| 58 | Chemical Biology and Drug Design | 6.1 | 64th | Q2 | SCIE | – | No |
| 59 | Current Drug Targets | 6 | 63rd | Q2 | SCIE | – | No |
| 60 | Therapeutic Advances in Vaccines and Immunotherapy | 6 | 63rd | Q2 | – | – | Yes |
| 61 | Chirality | 5.9 | 62nd | Q2 | SCIE | – | No |
| 62 | Current Pharmaceutical Design | 5.8 | 61st | Q2 | SCIE | – | No |
| 63 | Journal of the Indian Chemical Society | 5.8 | 61st | Q2 | SCIE | – | No |
| 64 | ChemMedChem | 5.7 | 60th | Q2 | SCIE | – | No |
| 65 | RSC Medicinal Chemistry | 5.7 | 59th | Q2 | SCIE | – | No |
| 66 | Recent Patents on Anti-Cancer Drug Discovery | 5.6 | 59th | Q2 | SCIE | – | No |
| 67 | ACS Medicinal Chemistry Letters | 5.6 | 58th | Q2 | SCIE | – | No |
| 68 | Bioorganic and Medicinal Chemistry | 5.6 | 58th | Q2 | SCIE | – | No |
| 69 | International Journal of Peptide Research and Therapeutics | 5.3 | 57th | Q2 | SCIE | – | No |
| 70 | Iranian Journal of Basic Medical Sciences | 5.2 | 56th | Q2 | SCIE | – | Yes |
| 71 | Journal of Natural Medicines | 5.2 | 56th | Q2 | SCIE | – | No |
| 72 | Phytochemical Analysis | 5.2 | 55th | Q2 | SCIE | – | No |
| 73 | Frontiers in Antibiotics | 5 | 54th | Q2 | ESCI | – | Yes |
| 74 | Frontiers in Drug Discovery | 5 | 54th | Q2 | ESCI | – | Yes |
| 75 | Current Opinion in Systems Biology | 5 | 53rd | Q2 | ESCI | – | No |
| 76 | Medicinal Chemistry | 5 | 53rd | Q2 | SCIE | – | No |
| 77 | Antibodies | 4.9 | 52nd | Q2 | ESCI | – | Yes |
| 78 | International Journal of Cosmetic Science | 4.8 | 51st | Q2 | SCIE | – | No |
| 79 | Journal of Gene Medicine | 4.8 | 51st | Q2 | SCIE | – | No |
| 80 | DARU, Journal of Pharmaceutical Sciences | 4.8 | 50th | Q2 | SCIE | – | No |
| 81 | Journal of Basic and Clinical Physiology and Pharmacology | 4.7 | 50th | Q2 | – | – | No |
| 82 | npj Systems Biology and Applications | 4.7 | 49th | Q3 | SCIE | – | Yes |
| 83 | Planta Medica | 4.7 | 48th | Q3 | SCIE | – | No |
| 84 | Journal of Antibiotics | 4.6 | 48th | Q3 | SCIE | – | No |
| 85 | Current Pharmacology Reports | 4.6 | 47th | Q3 | ESCI | – | No |
| 86 | Drug Research | 4.6 | 46th | Q3 | ESCI | – | No |
| 87 | Journal of Computer-Aided Molecular Design | 4.6 | 46th | Q3 | SCIE | – | No |
| 88 | Bioorganic and Medicinal Chemistry Letters | 4.5 | 45th | Q3 | SCIE | – | No |
| 89 | SAR and QSAR in Environmental Research | 4.4 | 45th | Q3 | SCIE | – | No |
| 90 | Cancer Innovation | 4.4 | 44th | Q3 | ESCI | – | Yes |
| 91 | Future Medicinal Chemistry | 4.4 | 43rd | Q3 | SCIE | – | No |
| 92 | Avicenna Journal of Phytomedicine | 4.3 | 43rd | Q3 | ESCI | – | Yes |
| 93 | Journal of Medicinal and Chemical Sciences | 4.3 | 42nd | Q3 | – | – | No |
| 94 | Current Cancer Drug Targets | 4.2 | 41st | Q3 | SCIE | – | No |
| 95 | Journal of Ayurveda and Integrative Medicine | 4.2 | 41st | Q3 | ESCI | – | Yes |
| 96 | Medinformatics | 4 | 40th | Q3 | – | – | No |
| 97 | Fitoterapia | 3.9 | 40th | Q3 | SCIE | – | No |
| 98 | Studies in Natural Products Chemistry | 3.9 | 39th | Q3 | – | – | No |
| 99 | Assay and Drug Development Technologies | 3.8 | 38th | Q3 | SCIE | – | No |
| 100 | Journal of Peptide Science | 3.8 | 38th | Q3 | SCIE | – | No |
| 101 | Tetrahedron | 3.7 | 37th | Q3 | SCIE | – | No |
| 102 | Combinatorial Chemistry and High Throughput Screening | 3.6 | 36th | Q3 | SCIE | – | No |
| 103 | Trends in Phytochemical Research | 3.6 | 36th | Q3 | – | – | No |
| 104 | Chemotherapy | 3.6 | 35th | Q3 | SCIE | – | No |
| 105 | Drug Development and Industrial Pharmacy | 3.6 | 35th | Q3 | SCIE | – | No |
| 106 | Journal of Pharmaceutical Innovation | 3.5 | 34th | Q3 | SCIE | – | No |
| 107 | Biomedical Chromatography | 3.3 | 33rd | Q3 | SCIE | – | No |
| 108 | International Journal of Medicinal Mushrooms | 3.3 | 33rd | Q3 | SCIE | – | No |
| 109 | Pharmaceutical Patent Analyst | 3.2 | 32nd | Q3 | – | – | No |
| 110 | Biomarkers in Medicine | 3.2 | 31st | Q3 | SCIE | – | No |
| 111 | Records of Natural Products | 3.2 | 31st | Q3 | SCIE | – | No |
| 112 | Journal of HerbMed Pharmacology | 3 | 30th | Q3 | – | – | Yes |
| 113 | Helvetica Chimica Acta | 2.9 | 30th | Q3 | SCIE | – | No |
| 114 | Current Computer-Aided Drug Design | 2.9 | 29th | Q3 | SCIE | – | No |
| 115 | Current Drug Discovery Technologies | 2.9 | 28th | Q3 | – | – | No |
| 116 | Tetrahedron Letters | 2.8 | 28th | Q3 | SCIE | – | No |
| 117 | Emerging Trends in Drugs, Addictions, and Health | 2.8 | 27th | Q3 | – | – | Yes |
| 118 | Journal of Asian Natural Products Research | 2.8 | 27th | Q3 | SCIE | – | No |
| 119 | Natural Product Communications | 2.7 | 26th | Q3 | SCIE | – | Yes |
| 120 | Pharmacognosy Journal | 2.5 | 25th | Q3 | – | – | No |
| 121 | Recent Advances in Anti-Infective Drug Discovery | 2.5 | 25th | Q3 | – | – | No |
| 122 | Journal of Pharmacy and Pharmacognosy Research | 2.5 | 24th | Q4 | ESCI | – | Yes |
| 123 | Chemical and Pharmaceutical Bulletin | 2.4 | 23rd | Q4 | SCIE | – | No |
| 124 | Expert Review of Precision Medicine and Drug Development | 2.3 | 23rd | Q4 | ESCI | – | No |
| 125 | Journal of Biologically Active Products from Nature | 2.3 | 22nd | Q4 | ESCI | – | No |
| 126 | Natural Products Journal | 2.3 | 22nd | Q4 | ESCI | – | No |
| 127 | Letters in Drug Design and Discovery | 2.2 | 21st | Q4 | SCIE | – | No |
| 128 | Recent Advances in Inflammation and Allergy Drug Discovery | 2 | 20th | Q4 | ESCI | – | No |
| 129 | Tropical Journal of Natural Product Research | 1.9 | 20th | Q4 | – | – | No |
| 130 | Research Journal of Pharmacognosy | 1.9 | 19th | Q4 | ESCI | – | Yes |
| 131 | Journal of Labelled Compounds and Radiopharmaceuticals | 1.9 | 18th | Q4 | SCIE | – | No |
| 132 | Natural Product Sciences | 1.8 | 18th | Q4 | – | – | No |
| 133 | Current Traditional Medicine | 1.7 | 17th | Q4 | ESCI | – | No |
| 134 | International Journal of Drug Discovery and Pharmacology | 1.7 | 17th | Q4 | – | – | Yes |
| 135 | Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas | 1.6 | 16th | Q4 | SCIE | – | No |
| 136 | Aging Pathobiology and Therapeutics | 1.6 | 15th | Q4 | – | – | No |
| 137 | Pharmaceutical Chemistry Journal | 1.6 | 15th | Q4 | SCIE | – | No |
| 138 | Chinese Traditional and Herbal Drugs | 1.5 | 14th | Q4 | – | – | No |
| 139 | Current Enzyme Inhibition | 1.5 | 13th | Q4 | – | – | No |
| 140 | Topics in Medicinal Chemistry | 1.4 | 13th | Q4 | – | – | No |
| 141 | Drug Development and Registration | 1.1 | 12th | Q4 | – | – | Yes |
| 142 | Current Trends in Biotechnology and Pharmacy | 0.9 | 12th | Q4 | – | – | No |
| 143 | RSC Drug Discovery Series | 0.9 | 11th | Q4 | – | – | No |
| 144 | Chinese Journal of Modern Applied Pharmacy | 0.8 | 10th | Q4 | – | – | No |
| 145 | Medicinal Plants - International Journal of Phytomedicines and Related Industries | 0.7 | 10th | Q4 | – | – | No |
| 146 | Ukrains'kij Zurnal Vijskovoi Medicini | 0.7 | 9th | Q4 | – | – | Yes |
| 147 | Life Sciences, Medicine and Biomedicine | 0.6 | 9th | Q4 | – | – | Yes |
| 148 | International Journal of Advanced Science and Engineering | 0.6 | 8th | Q4 | – | – | No |
| 149 | China Pharmacy | 0.6 | 7th | Q4 | – | – | Yes |
| 150 | International Journal of Computational Biology and Drug Design | 0.6 | 7th | Q4 | – | – | No |
| 151 | Indian Drugs | 0.6 | 6th | Q4 | – | – | No |
| 152 | Cancer Drug Discovery and Development | 0.5 | 5th | Q4 | – | – | No |
| 153 | Journal of Natural Remedies | 0.5 | 5th | Q4 | – | – | No |
| 154 | Medicinal Chemistry Reviews | 0.5 | 4th | Q4 | – | – | No |
| 155 | Chinese Journal of Clinical Pharmacology and Therapeutics | 0.4 | 4th | Q4 | – | – | No |
| 156 | VacciMonitor | 0.4 | 3rd | Q4 | – | – | Yes |
| 157 | Drugs and Clinic | 0.3 | 2nd | Q4 | – | – | No |
| 158 | Korean Journal of Pharmacognosy | 0.3 | 2nd | Q4 | – | – | No |
| 159 | European Health and Pharmaceutical Law Review | 0.2 | 1st | Q4 | – | – | No |
| 160 | Asian Journal of Pharmaceutical and Clinical Research | 0.2 | 0th | Q4 | – | – | No |
| 161 | Revista Cubana de Plantas Medicinales | 0.1 | 0th | Q4 | – | – | No |